POLG2 and cancer: In 2016, Sayantan Datta et al.  adopted Illumina Golden Gate analysis to explore the association between oral precancerous lesions and cancer risk factors in cancer patients, patients with precancerous lesions (leukoplakia) and healthy controls, with the finding that Rs9905016 of POLG2 significantly elevated the risk of oral cancer.